miR‐1307 is an important anti‐apoptotic oncoprotein, known to promote chemotherapy resistance in ovarian cancer by targeting ING5 expression, and miR‐1307 may be a therapeutic target for ovarian cancer.40 Here, ING5 is linked to ovarian cancer.